Climate change and emerging diseases: challenges for physicians in Canada Authors: Eleni Galanis, Nicholas H. Ogden Published: 2026 Key points Climate change is driving the emergence and re-emergence of climate-sensitive infectious diseases in Canada. Climate change is driving the emergence and re-emergence of climate-sensitive infectious diseases in Canada. Such emerging diseases pose health risks and diagnostic challenges in new regions of Canada. Such emerging diseases pose health risks and diagnostic challenges in new regions of Canada. Physicians play a key role in identifying where and when these diseases emerge and alerting public health professionals to cases. Physicians play a key role in identifying where and when these diseases emerge and alerting public health professionals to cases. This issue of CMAJ contains 2 articles that discuss tick-borne infectious diseases that may be acquired in Canada. Masoudifar and colleagues discuss Rocky Mountain Spotted Fever (RMSF),1 and Moshref Razavi and colleagues describe a case of tick-borne relapsing fever (TBRF).2 In recent decades, changes in temperature and precipitation patterns related to anthropogenic climate change have driven the emergence of climate-sensitive infectious diseases, particularly tick- and other vector-borne diseases, in regions where they were previously not endemic. We discuss tick- and mosquito-borne diseases that pose increased risks to people in Canada because of climate change. Climate change can drive disease emergence by increasing survival and geographic distributions of pathogens, vectors, and animal reservoir hosts, as well as by affecting human behaviour.3 The risk from climate-sensitive diseases already common in Canada is increasing. For instance, Lyme disease has become endemic in parts of Canada because its vector, the deer tick Ixodes scapularis, has expanded its range, driven by warming that is strongly attributed to human-induced climate change.4 Rare but endemic climate-sensitive diseases are re-emerging in Canada. In 2024, 3 pediatric cases of meningoencephalitis caused by the mosquito-borne snowshoe hare virus occurred in Whistler, British Columbia.5 In 2025, 2 humans and several dogs developed RMSF in southern Ontario.6 These diseases are known to occur sporadically in parts of southern Canada but not usually in clusters of several cases at the same time in the same place. Climate change may be leading to ecological changes that increase the abundance of vectors, infection rates in these vectors, and cases of vector-borne disease in people.3 The incidence of other endemic vector-borne disease in Canada may remain stable. One such disease is TBRF, which is transmitted by a soft-bodied tick present in southeastern BC. Human infections have been identified occasionally in BC for decades.7 Although climate change does not seem to have led to changes in incidence to date, knowledge gaps limit predictions. Scientists anticipate range expansion northward and to higher altitudes in mountainous areas.8 The risk of infection with West Nile virus likewise remains unchanged for now but is expected to increase as climate change drives increases in the abundance and geographic distribution of Culex spp. mosquitoes and environments suitable for transmission within Canada.3 Tropical vector-borne diseases may also emerge in Canada. Given the climate-driven establishment of Aedes albopictus (also known as the Asian tiger mosquito) in the southernmost tip of Ontario,9 a returning traveller infected with dengue, chikungunya, or Zika virus could now lead to the infection of local mosquitoes that, in turn, could transmit the virus locally to others during the warmest months. Patients presenting with such infections in nonendemic locations and with no history of recent travel pose a challenge for physicians. Physicians may be unfamiliar with the clinical presentation, laboratory diagnosis, and optimal treatment of nonendemic diseases or not think to include these in their differential diagnosis. The consequences of misdiagnosis and delayed or nonoptimal treatment may be more severe illness and poorer patient outcomes. For example, a patient seeking care for a non-specific febrile illness in a geographic region where the bacterium Rickettsia rickettsii has not previously been identified, may not be treated with doxycycline, the antibiotic of choice for RMSF.10 Physicians should ask about a history of outdoor activities and possible exposure to insect bites even if patients have not travelled to known endemic areas. They can consult with their public health reference laboratory for guidance on tests to diagnose these diseases. Different vector-borne diseases are reportable in different provinces and territories; however, any unusual disease cluster should be reported to public health authorities to alert them to patterns that may indicate an emerging disease or an outbreak. The investigation of emerging diseases is a collaborative endeavour. Public health scientists model current risk and, in collaboration with climatologists, predict when and where risk of infection may increase in the future.11 Modelling studies and disease reporting and modelling inform public health professionals’ decisions about where and when to investigate health risks and conduct surveillance for emerging pathogens, vectors, and human infections. Innovations in surveillance, such as citizen science approaches, where members of the public find and submit specimens or photographs of ticks or mosquitoes to scientists for identification, can augment standard methods.12,13 Armed with knowledge about new locations of emerging diseases, public health professionals target prevention messages to the public and physicians. They work with behavioural scientists, risk communicators, and outdoors specialists to craft and deliver the right message to the right audience. Primary care providers are uniquely placed to reinforce prevention messages with their patients in the spring and summer. Insect bites can be prevented by wearing clothing that covers the skin, using repellents, inspecting skin for ticks, staying on trails, staying indoors during peak mosquito-biting activity, using screens on doors and windows, and removing standing water. Scientists cannot yet anticipate trends in the risk or incidence of RMSF or TBRF in Canada, but research is ongoing. New climate-sensitive diseases will likely emerge in Canada, and some may become endemic. If a new vector-borne disease establishes itself, scientists may advise governments on control of the abundance of vectors through landscaping and community pesticide use, while ongoing research investigates vaccines and novel methods of vector control, such as the use of genetically modified mosquitoes.14 People in Canada are observing the substantial effects of climate change on human health. Physicians can prepare by familiarizing themselves with potential climate-sensitive diseases in their regions and maintaining a high index of suspicion in the appropriate clinical context. Along with scientists, physicians can share information, advocate for climate-friendly policies, and work with nongovernmental organizations and their own health and science associations to develop collective adaptation responses.